Related Experiment Videos
[Lipid profile in maintenance haemodialysis]
1Laboratoire de biochimie, CHU Habib-Bourguiba, Sfax, Tunisie. jamoussikamel@yahoo.fr
Pathologie-Biologie
|April 27, 2005
Summary
Patients with end-stage renal disease on maintenance hemodialysis exhibit significant lipid disturbances, including higher triglycerides and lower HDL cholesterol. These changes complicate the assessment of cardiovascular risk in this population.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Clinical Chemistry
Context:
- Chronic kidney failure leads to dyslipidemia and accelerated atherosclerosis.
- Dialysis does not reverse lipoprotein profile changes.
- End-stage renal disease (ESRD) patients face significant cardiovascular risks.
Purpose:
- To characterize lipid disturbances in ESRD patients.
- To assess the atherogenic potential of these lipid changes.
- To evaluate the utility of lipid profiles in predicting cardiovascular risk in dialysis patients.
Summary:
- Hemodialysis patients showed significantly higher triglyceride levels.
- High-density-lipoprotein cholesterol and apolipoprotein AI levels were significantly reduced in patients.
- Low-density-lipoprotein cholesterol and apolipoprotein B levels did not increase, and the LDL/HDL ratio was not a useful risk indicator.
Impact:
- Confirms quantitative lipid disorders in maintenance hemodialysis.
- Highlights the difficulty in assessing cardiovascular risk based solely on lipid profiles in ESRD.
- Suggests a need for alternative or additional cardiovascular risk assessment strategies in dialysis patients.